ARYA Sciences Acquisition Corp IV (ARYD)
| Previous close | 11.35 |
| Open | 11.35 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 11.35 - 11.35 |
| 52-week range | 10.43 - 11.39 |
| Volume | |
| Avg. volume | 41,232 |
| Market cap | 85.54M |
| Beta (5Y monthly) | -0.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.22 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireAdagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies
Adagio Medical, Inc. ("Adagio Medical"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, and ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) ("ARYA"), a special purpose acquisition company that is sponsored by an affiliate of Perceptive Advisors, LLC ("Perceptive Advisors"), today announced they have entered a definitive agreement (the "business combination agreement") for a business combination (the "transaction"). Upon closing of the transaction, Ad
Insider MonkeyFarallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks
In this article, we discuss Farallon Capital: a global and diversified hedge fund and its top stock picks. If you want to skip our detailed analysis of these stocks, go directly to the Top 5 Stock Picks of Farallon Capital. Risk arbitrage or merger arbitrage is one of the most popular strategies that hedge funds […]
